Kinneir Dufort is a design and product development consultancy that specializes in healthcare. The consultancy focuses on innovating, designing, and developing products and experiences for healthcare organizations, assisting in addressing user needs and bringing innovations to market.

Kinneir Dufort

Medical Equipment Manufacturing

SteriPack Group

Kinneir Dufort | SteriPack Design &amp; Product Development | 8,090 followers on LinkedIn. Designing a Better World | KD is a user-centred innovation and product development consultancy within the SteriPack Group. With 40+ years of experience and teams in the UK and US, we focus on designing a better world - developing innovative solutions for our healthcare clients, transforming how they address users’ needs and supporting them through the journey to manufacture.

Head of Continuous Improvement at Kinneir Dufort, A SteriPack Company

Tony Wood

Chief Design Officer at Kinneir Dufort

Craig Wightman

Foresight and design driven product & service innovation - Connecting cultures, technology, people - D&AD Winner

Josh Wasserman

Financial Controller at Kinneir Dufort

Michelle Gardiner

Kinneir Dufort | SteriPack Design & Product Development

Working in partnership with the world’s largest pharma and medical device companies, our team of drug delivery experts work to develop impactful combination products and delivery technologies that empower patients and improve adherence to life changing medication. Our team can help you with your journey from design, right through to manufacture, and will help you to explore: - Device or technology innovation - Existing platform customisation - Sustainability engineering - Third party assessments - Finite Element Analysis (FEA) & simulation - Usability engineering - Secondary packaging design Find out more here: https://lnkd.in/e4fRrHNM And of course please get in touch if you would like to discuss your drug delivery device needs, we would love to hear from you: hello@kinneirdufort.com #Healthcare #DrugDelivery #Pharma #ProductDevelopment SteriPack Group

Our Human Factors team will be exhibiting at the first BSI Young Professionals Exchange next week on November 20th! The networking event sets to provide young professionals with an opportunity to understand how the UK's national standards body shapes industry and the world around us. If you're already involved in standards development currently, or you have a keen interest, come along to discover how you can help to shape a better future through standards. Natalie Shortt , who is already a volunteer committee member with a BSI committee, and Molly Smyth , one of our Senior Human Factors Specialists, will be in attendance and ready to answer your questions! Register today: https://bit.ly/4chNWCv #BSI #BSIYPExchange #HumanFactors

Did you know that around 1 in 6 people worldwide are affected by infertility? While infertility ultimately affects a great deal of the global population, successful outcomes for fertility treatments can often be overlooked and underfunded. We're pleased to work with organisations like Verso Biosense , who are making great progress in this space as they look to improve IVF outcomes for patients with the development of their connected intrauterine device, Iris. Iris has been created to increase the success rates of IVF for users, and reduce the total cost of the procedure. The implantable device has novel integrated uterine oxygen and temperature sensors, and wireless connectivity. Find out more about the technology, here: https://lnkd.in/eM8b_sgt #WomensHealth #IVF #Healthcare #MedicalDevices SteriPack Group

Mesh nebulisers have gained significant popularity as a method of drug delivery for patients as the prevalence of respiratory diseases increases. Mesh nebulisation has a broad range of advantages for patient care, yet there are still challenges - particularly considering the various drug formulations and use-cases for these devices. Looking at the advantages and the challenges of mesh nebulisers as a drug delivery method, our Senior Electronics Engineer Richard Gold examines the efficacy and the obstacles surrounding mesh nebulisers. Click the link below to learn more about the complexities of this type of nebulisation technology and its impact on patient care: https://lnkd.in/euYEPxHM #DrugDelivery #Pharmaceuticals #ProductDevelopment SteriPack Group

FDA guidance is a crucial resource for the medical device industry; Understanding how to comply with regulatory requirements can help to streamline processes and avoid costly risks. The FDA regularly updates such guidance to reflect current practices and technology. But did you know that draft guidance comes with an opportunity to submit comments or suggest changes for consideration before the final guidance is issued? In our latest article, our business development manager and Human Factors specialist, Natalie Shortt provides an overview of how industry professionals can engage with the FDA draft guidance feedback process and the benefits that this can bring. Read more here: https://lnkd.in/esfMMtTZ #FDA #HumanFactors #Healthcare SteriPack Group

It has been a busy, invigorating 4 weeks of showcasing our pharmaceutical expertise at various conferences side by side with our SteriPack Group colleagues! From Milan to Arizona and then on to Boston - that's a wrap! Our teams had an excellent time at CPHI , PDA - Parenteral Drug Association and PODD. From Lucy Baldwin taking to the stage at PDA with Agata Pczycka of AstraZeneca to discuss designing inclusive packaging ecosystems, to meeting a whole host of businesses to discuss the future of their projects - what a month! Thank you to everyone we met along the way. It was a pleasure to hear more about your goals and challenges. If you didn't have chance to connect with us, but would like to know more about our design and product development experience in the pharmaceutical sector, just drop us a line at hello@kinneirdufort.com #Pharma #DrugDeliveryDevices #CPHI #PODD #PDA Sunny Panesar Kerry Briggs Joe Masci Phillip Jackson David Moore Marcel Baumann John Ward

Will you be attending this year's Compamed MEDICA - Leading International Trade Fair ? Join our Business Development Manager, Anthony McAllister , and the SteriPack Group team in Düsseldorf, Germany, from 11th - 14th November! The team will be on hand to answer your questions about taking your medical device to market at speed. Get in touch with Anthony if you would like to set up a meeting or find out more. #Medica #Healthcare #Medica2024 #Compamed2024

After attending an insightful PDA - Parenteral Drug Association , our Head of Research & Strategy Lucy Baldwin , and Principal Design Consultant Phillip Jackson , continued their travels and spent a number of days working with our USA design and development team in Morristown. Lucy reflects on the value of their time with our USA colleagues: "While in the states for a conference we took the opportunity to visit our fantastic design & development colleagues in Morristown, New Jersey. Our end to end capability and facilities in both the UK & US sites means we can field projects more efficiently, and with deep knowledge of local markets. As well as progressing a number of exciting projects together, we of course also took the time to enjoy fall in full swing, and sample some culinary delights." We work closely with our US team, despite the distance, but it's always great to make the most of the time we have with the team in person. #Design #ProductDevelopment #Healthcare SteriPack Group

We're currently recruiting for two brilliant university placement interns to join us! The 12-month positions will begin in 2025 and sit within our Engineering and Electronics & Software teams. Previous interns have gone on to work in amazing careers, and we're proud to say that a number have also gone on to work permanently within our team. Below is just some of the feedback we have had from previous interns over the past year. If you're interested, you can find out more here: https://lnkd.in/eKDn3qNX #Internships #Engineering #Electronics SteriPack Group

Our team are all set for day two at the annual PODD: Partnership Opportunities in Drug Delivery Community News (PODD) Conference in Boston, USA! It has been a great conference so far, with the team connecting with leaders across the pharmaceutical, biotech and drug delivery industries. Are you attending? Find our team on booth #60, ready to discuss your pharmaceutical drug delivery device needs. Head of Sales, Sunny Panesar , will be there alongside US Business Development lead Joe Masci , and Marcel Baumann and David Moore from the wider SteriPack Group manufacturing team. #DrugDelivery #Pharma #Healthcare SteriPack Group

Metric
Company Name	Kinneir Dufort
Symbol
MSH ID	COM:KINNEIRDUFORT
Market	PRIVATE
Sector	Commercial & Professional Services
Industry	Healthcare & Health Services
Country	GB
Stage
Employee Count
Website	kinneirdufort.com
LinkedIn	kinneir-dufort
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	634
Web Traffic Growth	-0.40
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

KINN

COM:KINNEIRDUFORT

Kinneir Dufort

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue